{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:22:47Z","timestamp":1769170967239,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.leukres.2021.106511","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T03:51:46Z","timestamp":1611028306000},"page":"106511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia"],"prefix":"10.1016","volume":"101","author":[{"given":"Guillermo","family":"Montalban-Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Darbaniyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-3139","authenticated-orcid":false,"given":"Irene","family":"Ganan-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-3613","authenticated-orcid":false,"given":"Caleb A.","family":"Class","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Soltysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-1613","authenticated-orcid":false,"given":"Kelly S.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Anh","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.leukres.2021.106511_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2021.106511_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2021.106511_bib0015","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/leu.2017.164","article-title":"Genomic determinants of chronic myelomonocytic leukemia","volume":"31","author":"Patel","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2021.106511_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood-2013-05-500272","article-title":"Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2021.106511_bib0025","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1172\/JCI70739","article-title":"Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations","volume":"123","author":"Inoue","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.leukres.2021.106511_bib0030","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20131141","article-title":"Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo","volume":"210","author":"Abdel-Wahab","year":"2013","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.leukres.2021.106511_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.leukres.2021.106511_bib0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6327","key":"10.1016\/j.leukres.2021.106511_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.leukres.2021.106511_bib0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm.4097","article-title":"Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.leukres.2021.106511_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1016\/j.leukres.2021.106511_bib0060","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2021.106511_bib0065","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/bloodadvances.2018024166","article-title":"KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice","volume":"2","author":"Wei","year":"2018","journal-title":"Blood Adv."},{"issue":"Supplement_1","key":"10.1016\/j.leukres.2021.106511_bib0070","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood-2019-122574","article-title":"KDM6B overexpression and TET2 deficiency cooperatively drive development of myelodysplastic syndrome and chronic myelomonocytic leukemia-like phenotype in mice","volume":"134","author":"Wei","year":"2019","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.leukres.2021.106511_bib0075","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106511_bib0080","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.leukres.2021.106511_bib0085","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.leukres.2021.106511_bib0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"43","key":"10.1016\/j.leukres.2021.106511_bib0095","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.leukres.2021.106511_bib0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00018-013-1322-4","article-title":"Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks","volume":"71","author":"Huber","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.leukres.2021.106511_bib0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjh.14467","article-title":"Maturation-associated gene expression profiles along normal human bone marrow monopoiesis","volume":"176","author":"Mello","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106511_bib0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.stem.2007.07.005","article-title":"Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy","volume":"1","author":"Pronk","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.leukres.2021.106511_bib0115","series-title":"My Stepwise: Stepwise Variable Selection Procerues for Regression Analysis, Version 0.1.0.","author":"Hu","year":"2017"},{"issue":"3","key":"10.1016\/j.leukres.2021.106511_bib0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","author":"Contal","year":"1999","journal-title":"Comput. Stat. Data Anal."},{"key":"10.1016\/j.leukres.2021.106511_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102904","article-title":"Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome","volume":"58","author":"Wiseman","year":"2020","journal-title":"EBioMedicine."},{"issue":"15","key":"10.1016\/j.leukres.2021.106511_bib0130","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/bloodadvances.2018019224","article-title":"Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories","volume":"2","author":"Loghavi","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2021.106511_bib0135","article-title":"Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes","author":"Ganan-Gomez","year":"2015","journal-title":"Leukemia."},{"issue":"9","key":"10.1016\/j.leukres.2021.106511_bib0140","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/leu.2013.180","article-title":"Toll-like receptor alterations in myelodysplastic syndrome","volume":"27","author":"Wei","year":"2013","journal-title":"Leukemia."},{"issue":"6","key":"10.1016\/j.leukres.2021.106511_bib0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","article-title":"Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis","volume":"75","author":"Stifter","year":"2005","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106511_bib0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ejh.12074","article-title":"Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-alpha by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes","volume":"90","author":"Zhang","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106511_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120602","article-title":"Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.leukres.2021.106511_bib0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-Dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell."},{"issue":"8","key":"10.1016\/j.leukres.2021.106511_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007234","article-title":"Type I IFNs drive hematopoietic stem and progenitor cell collapse via impaired proliferation and increased RIPK1-dependent cell death during shock-like ehrlichial infection","volume":"14","author":"Smith","year":"2018","journal-title":"PLoS Pathog."},{"issue":"14","key":"10.1016\/j.leukres.2021.106511_bib0170","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/bloodadvances.2017004903","article-title":"Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines","volume":"1","author":"Zhang","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2021.106511_bib0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41375-018-0203-0","article-title":"Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML","volume":"33","author":"Niyongere","year":"2019","journal-title":"Leukemia."},{"key":"10.1016\/j.leukres.2021.106511_bib0180","series-title":"Presented at the 61st Annual Meeting of the American Society of Hematology(Abstract #562)","article-title":"KDM6B overexpression and TET2 deficiency cooperatively Drive development of myelodysplastic syndrome and chronic myelomonocytic leukemia-like phenotype in mice","author":"Wei","year":"2019"},{"issue":"7","key":"10.1016\/j.leukres.2021.106511_bib0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ajh.24746","article-title":"An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes","volume":"92","author":"Daher","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2021.106511_bib0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.leukres.2018.09.004","article-title":"Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation","volume":"73","author":"Abaza","year":"2018","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2021.106511_bib0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.24972","article-title":"A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"93","author":"Assi","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"15","key":"10.1016\/j.leukres.2021.106511_bib0200","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1158\/1078-0432.CCR-15-2781","article-title":"A multi-institution phase I trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)","volume":"22","author":"Padron","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.leukres.2021.106511_bib0205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2019004352","article-title":"Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia","volume":"136","author":"Patnaik","year":"2020","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2021.106511_bib0210","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","article-title":"The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations","volume":"3","author":"Franzini","year":"2019","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.leukres.2021.106511_bib0215","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1172\/JCI67580","article-title":"Induction of myelodysplasia by myeloid-derived suppressor cells","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:43Z","timestamp":1758934843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":43,"alternative-id":["S0145212621000126"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106511","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106511"}}